nalidixic acid has been researched along with E coli Infections in 142 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of a 3-day course of nalidixic acid was studied in 82 women, presenting with the dysuria-frequency syndrome and significant bacteriuria, mostly Escherichia coli sensitive to nalidixic acid." | 7.66 | Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women. ( Ahlmén, J; Bucht, H; Calmenius, C; Merck, C; Sigurdsson, J; Wohrm, A, 1983) |
| "Resistance to ciprofloxacin in Escherichia coli from urinary tract infections (UTI) in Denmark is increasing parallel to increased use of fluoroquinolones both in Denmark and in other European countries." | 3.77 | Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country. ( Christiansen, N; Frimodt-Møller, N; Hansen, LH; Jakobsen, L; Nielsen, L; Stegger, M, 2011) |
| " coli blood isolates from patients with urosepsis for their susceptibility to nalidixic acid, ampicillin and trimethoprim-sulfamethoxazole, according to prevalence of virulence factors, phylogenetic groups and subgroups, PAI II(J96)-like domains (determined by physical linkage of cnf1, hly and hra) and PAI I(CFT073)-like domains (determined by physical linkage of papGII to the hly locus)." | 3.73 | Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. ( Barraud, D; Bidet, P; Bingen, E; Bingen-Bidois, M; Bonacorsi, S; Houdouin, V, 2006) |
| "The prevalence of hemolysin, type 1 fimbriae, P fimbriae, cytotoxic necrotizing factor-1 (CNF-1), aerobactin, and autotransporter toxin (sat) was analyzed by polymerase chain reaction and phenotypic assays of 42 epidemiologically unrelated Escherichia coli strains causing acute pyelonephritis in women (21 nalidixic acid-susceptible and 21 nalidixic acid-resistant strains) and 58 E." | 3.71 | Are quinolone-resistant uropathogenic Escherichia coli less virulent? ( Barranco, M; Horcajada, JP; Mensa, J; Moreno, A; Ruiz, J; Simon, K; Velasco, M; Vila, J, 2002) |
| "The effect of a 3-day course of nalidixic acid was studied in 82 women, presenting with the dysuria-frequency syndrome and significant bacteriuria, mostly Escherichia coli sensitive to nalidixic acid." | 3.66 | Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women. ( Ahlmén, J; Bucht, H; Calmenius, C; Merck, C; Sigurdsson, J; Wohrm, A, 1983) |
| "cinoxacin were compared to 1 g." | 2.65 | A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection. ( Bucy, JG, 1981) |
| "Ampicillin (84." | 1.48 | Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli. ( Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME, 2018) |
| "The empiric treatment of acute pyelonephritis (APN) with third generation cephalosporins (3GC) or fluoroquinolones (FQ) has been challenged by Escherichia coli resistance reported by community surveillance networks." | 1.40 | Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors. ( Caron, F; Choplin-Renard, J; Etienne, M; Pestel-Caron, M; Van Elslande, H, 2014) |
| "Ciprofloxacin resistance was associated with certain specific clones, among them the globally distributed clonal Group A." | 1.40 | High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen? ( Allum, AG; Grude, N; Henriksen, IH; Jenkins, A; Kristiansen, BE; Strand, L, 2014) |
| " coli resistant to nalidixic acid, it was necessary to evaluate the MIC of ciprofloxacin in order to asses the optimal dosage of ciprofloxacin." | 1.35 | Optimization of the use of ciprofloxacin. ( Aubert, G; Carricajo, A; Fonsale, N; Vautrin, AC, 2009) |
| "Norfloxacin was the most active antimicrobial agent tested against all isolates studied; it was the only agent active against P." | 1.27 | Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance. ( Appleman, MD; Corigliano, BE; Heseltine, PN; Leedom, JM, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 82 (57.75) | 18.7374 |
| 1990's | 5 (3.52) | 18.2507 |
| 2000's | 26 (18.31) | 29.6817 |
| 2010's | 23 (16.20) | 24.3611 |
| 2020's | 6 (4.23) | 2.80 |
| Authors | Studies |
|---|---|
| Albrecht, HA | 1 |
| Beskid, G | 1 |
| Chan, KK | 1 |
| Christenson, JG | 1 |
| Cleeland, R | 1 |
| Deitcher, KH | 1 |
| Georgopapadakou, NH | 1 |
| Keith, DD | 1 |
| Pruess, DL | 1 |
| Sepinwall, J | 1 |
| Castanheira, M | 1 |
| Pereira, AS | 1 |
| Nicoletti, AG | 1 |
| Pignatari, AC | 1 |
| Barth, AL | 1 |
| Gales, AC | 1 |
| Yamane, K | 1 |
| Wachino, J | 1 |
| Suzuki, S | 1 |
| Kimura, K | 1 |
| Shibata, N | 1 |
| Kato, H | 1 |
| Shibayama, K | 1 |
| Konda, T | 1 |
| Arakawa, Y | 1 |
| Cattoir, V | 2 |
| Poirel, L | 2 |
| Nordmann, P | 2 |
| Bortolaia, V | 2 |
| Guardabassi, L | 2 |
| Trevisani, M | 1 |
| Bisgaard, M | 2 |
| Venturi, L | 1 |
| Bojesen, AM | 2 |
| Blango, MG | 1 |
| Mulvey, MA | 1 |
| Dos Santos, RL | 1 |
| Davanzo, EFA | 1 |
| Palma, JM | 1 |
| Castro, VHL | 1 |
| da Costa, HMB | 1 |
| Dallago, BSL | 1 |
| Perecmanis, S | 1 |
| Santana, ÂP | 1 |
| Sultana, KF | 1 |
| Akter, A | 1 |
| Saha, SR | 1 |
| Ahmed, F | 1 |
| Alam, S | 1 |
| Jafar, T | 1 |
| Saha, O | 1 |
| Jeanvoine, A | 1 |
| Bouxom, H | 1 |
| Leroy, J | 1 |
| Gbaguidi-Haore, H | 1 |
| Bertrand, X | 2 |
| Slekovec, C | 1 |
| Kalsy, M | 1 |
| Tonk, M | 1 |
| Hardt, M | 1 |
| Dobrindt, U | 1 |
| Zdybicka-Barabas, A | 1 |
| Cytrynska, M | 1 |
| Vilcinskas, A | 1 |
| Mukherjee, K | 1 |
| Osińska, M | 1 |
| Nowakiewicz, A | 1 |
| Zięba, P | 1 |
| Gnat, S | 1 |
| Łagowski, D | 1 |
| Trościańczyk, A | 1 |
| Gaurav, A | 1 |
| Gupta, V | 1 |
| Shrivastava, SK | 1 |
| Pathania, R | 1 |
| Li, Y | 1 |
| Luo, Q | 1 |
| Shi, X | 1 |
| Lin, Y | 1 |
| Qiu, Y | 1 |
| Lv, D | 1 |
| Jiang, Y | 1 |
| Chen, Q | 1 |
| Jiang, M | 1 |
| Ma, H | 1 |
| Cheng, J | 1 |
| Hu, Q | 1 |
| Batard, E | 1 |
| Vibet, MA | 1 |
| Thibaut, S | 1 |
| Corvec, S | 1 |
| Pivette, J | 1 |
| Lepelletier, D | 1 |
| Caillon, J | 1 |
| Montassier, E | 1 |
| Humphry, RW | 1 |
| Evans, J | 1 |
| Webster, C | 1 |
| Tongue, SC | 1 |
| Innocent, GT | 1 |
| Gunn, GJ | 3 |
| Taha, MME | 1 |
| Homeida, HE | 1 |
| Dafalla, OME | 1 |
| Abdelwahab, SI | 1 |
| Cho, S | 1 |
| Hiott, LM | 1 |
| Barrett, JB | 1 |
| McMillan, EA | 1 |
| House, SL | 1 |
| Humayoun, SB | 1 |
| Adams, ES | 1 |
| Jackson, CR | 1 |
| Frye, JG | 1 |
| Pons, MJ | 1 |
| Mosquito, S | 1 |
| Gomes, C | 1 |
| Del Valle, LJ | 1 |
| Ochoa, TJ | 1 |
| Ruiz, J | 3 |
| Etienne, M | 1 |
| Van Elslande, H | 1 |
| Choplin-Renard, J | 1 |
| Pestel-Caron, M | 1 |
| Caron, F | 1 |
| Bedoin, M | 1 |
| Cazorla, C | 1 |
| Lucht, F | 1 |
| Berthelot, P | 1 |
| Boyer, M | 1 |
| Carricajo, A | 2 |
| Guérin, T | 1 |
| Viallon, A | 1 |
| Strand, L | 1 |
| Jenkins, A | 1 |
| Henriksen, IH | 1 |
| Allum, AG | 1 |
| Grude, N | 1 |
| Kristiansen, BE | 1 |
| González-Soltero, R | 1 |
| García-Cañas, A | 1 |
| Mohedano, RB | 1 |
| Mendoza-Chamizo, B | 1 |
| Botello, E | 1 |
| Grillo-Puertas, M | 1 |
| Martínez-Zamora, MG | 1 |
| Rintoul, MR | 1 |
| Soto, SM | 1 |
| Rapisarda, VA | 1 |
| Jiménez-Belenguer, A | 1 |
| Doménech, E | 1 |
| Villagrá, A | 1 |
| Fenollar, A | 1 |
| Ferrús, MA | 1 |
| Wang, L | 1 |
| Nakamura, H | 1 |
| Kage-Nakadai, E | 1 |
| Hara-Kudo, Y | 1 |
| Nishikawa, Y | 1 |
| Sreerama, S | 1 |
| Sanderson, MW | 1 |
| Wilkerson, M | 1 |
| Nagaraja, TG | 1 |
| Erume, J | 1 |
| Berberov, EM | 1 |
| Moxley, RA | 1 |
| Christiansen, N | 1 |
| Nielsen, L | 2 |
| Jakobsen, L | 1 |
| Stegger, M | 1 |
| Hansen, LH | 1 |
| Frimodt-Møller, N | 2 |
| Karczmarczyk, M | 1 |
| Martins, M | 1 |
| Quinn, T | 1 |
| Leonard, N | 1 |
| Fanning, S | 1 |
| Elgorriaga-Islas, E | 1 |
| Guggiana-Nilo, P | 1 |
| Domínguez-Yévenes, M | 1 |
| González-Rocha, G | 1 |
| Mella-Montecinos, S | 1 |
| Labarca-Labarca, J | 1 |
| García-Cañete, P | 1 |
| Bello-Toledo, H | 1 |
| Nagano, T | 1 |
| Kitahara, R | 1 |
| Nagai, S | 1 |
| Lyhs, U | 1 |
| Ikonen, I | 1 |
| Pohjanvirta, T | 1 |
| Raninen, K | 1 |
| Perko-Mäkelä, P | 1 |
| Pelkonen, S | 1 |
| Tamang, MD | 1 |
| Nam, HM | 1 |
| Chae, MH | 1 |
| Kim, SR | 1 |
| Gurung, M | 1 |
| Jang, GC | 1 |
| Jung, SC | 1 |
| Lim, SK | 1 |
| Vila, J | 3 |
| Simon, K | 1 |
| Horcajada, JP | 2 |
| Velasco, M | 1 |
| Barranco, M | 1 |
| Moreno, A | 1 |
| Mensa, J | 2 |
| Cookson, AL | 1 |
| Wales, AD | 1 |
| Roe, JM | 1 |
| Hayes, CM | 1 |
| Pearson, GR | 1 |
| Woodward, MJ | 1 |
| Tsuji, H | 1 |
| Oshima, K | 1 |
| Hamada, K | 1 |
| Ishikawa, K | 1 |
| Hayashi, K | 1 |
| Johnson, JR | 3 |
| Murray, AC | 1 |
| Gajewski, A | 2 |
| Sullivan, M | 1 |
| Snippes, P | 1 |
| Kuskowski, MA | 1 |
| Smith, KE | 1 |
| JAMESON, RM | 3 |
| SWINNEY, J | 2 |
| SLADE, DA | 1 |
| BARLOW, AM | 1 |
| WARD-MCQUAID, JF | 1 |
| JICHLINSKI, D | 1 |
| MACIS, R | 2 |
| WARRES, HL | 1 |
| NISHIURA, T | 1 |
| YOKOYAMA, S | 1 |
| ISHIGAMI, Y | 1 |
| OKOSHI, M | 1 |
| IKIGAME, Y | 1 |
| TAKAMURA, M | 1 |
| FUJIMURA, S | 1 |
| DRAPER, JW | 1 |
| AKBARI, A | 1 |
| WARD, JN | 1 |
| GIBSON, GR | 1 |
| POTTS, IF | 1 |
| HOLLAND, JT | 1 |
| MONTGOMERIE, JZ | 1 |
| SANJURJO, LA | 1 |
| RODRIGUEZ, S | 1 |
| OKUN, H | 1 |
| HARLIN, HC | 1 |
| WILLIAMS, DI | 1 |
| McCabe, WR | 1 |
| Jackson, GG | 1 |
| SMART, JG | 1 |
| HEUGHAN, C | 1 |
| Fendukly, F | 1 |
| Karlsson, I | 1 |
| Hanson, HS | 1 |
| Kronvall, G | 1 |
| Dornbusch, K | 1 |
| Chaniotaki, S | 1 |
| Giakouppi, P | 1 |
| Tzouvelekis, LS | 1 |
| Panagiotakos, D | 1 |
| Kozanitou, M | 1 |
| Petrikkos, G | 1 |
| Avlami, A | 1 |
| Vatopoulos, AC | 1 |
| Talon, D | 1 |
| Lallemand-De-Conto, S | 1 |
| Thouverez, M | 1 |
| Hoyle, DV | 1 |
| Knight, HI | 1 |
| Shaw, DJ | 1 |
| Hillman, K | 1 |
| Pearce, MC | 1 |
| Low, JC | 2 |
| Woolhouse, ME | 1 |
| Mammeri, H | 1 |
| Van De Loo, M | 1 |
| Martinez-Martinez, L | 1 |
| Lecaillon, E | 1 |
| Blosser-Middleton, R | 1 |
| Sahm, D | 1 |
| Jones, M | 1 |
| Soto, S | 1 |
| Smithson, A | 1 |
| Jiménez de Anta, MT | 1 |
| Hannah, EL | 1 |
| Angulo, FJ | 1 |
| Haddadin, B | 1 |
| Williamson, J | 1 |
| Samore, MH | 1 |
| Lautenbach, E | 1 |
| Fishman, NO | 1 |
| Metlay, JP | 1 |
| Mao, X | 1 |
| Bilker, WB | 1 |
| Tolomeo, P | 1 |
| Nachamkin, I | 1 |
| Houdouin, V | 1 |
| Bonacorsi, S | 1 |
| Bidet, P | 1 |
| Bingen-Bidois, M | 1 |
| Barraud, D | 1 |
| Bingen, E | 1 |
| Lesprit, P | 1 |
| Lascols, C | 1 |
| Denamur, E | 1 |
| Legrand, P | 1 |
| Soussy, CJ | 1 |
| Cambau, E | 1 |
| Hall, M | 1 |
| Hunter, EA | 1 |
| Starcic Erjavec, M | 1 |
| Rijavec, M | 1 |
| Krizan-Hergouth, V | 1 |
| Fruth, A | 1 |
| Zgur-Bertok, D | 1 |
| Aubert, G | 1 |
| Fonsale, N | 1 |
| Vautrin, AC | 1 |
| Cavaco, LM | 1 |
| Hasman, H | 1 |
| Aarestrup, FM | 1 |
| Rylander, M | 1 |
| Norrby, SR | 1 |
| Corigliano, BE | 1 |
| Appleman, MD | 1 |
| Heseltine, PN | 1 |
| Leedom, JM | 1 |
| Peddie, BA | 1 |
| Little, PJ | 1 |
| Ahlmén, J | 1 |
| Sigurdsson, J | 1 |
| Wohrm, A | 1 |
| Calmenius, C | 1 |
| Merck, C | 1 |
| Bucht, H | 1 |
| Moulin, G | 1 |
| Martel, JL | 1 |
| Guillot, JF | 1 |
| Libmann, M | 1 |
| Contrepois, A | 1 |
| Daldoss, C | 1 |
| Pangon, B | 1 |
| Garaud, JJ | 1 |
| Kecir, M | 1 |
| Sarrazin, C | 1 |
| Vallois, JM | 1 |
| Carbon, C | 1 |
| Chantrie, M | 1 |
| Bucy, JG | 1 |
| McAllister, TA | 1 |
| Hussain, Z | 1 |
| Burchardt, P | 1 |
| Paulson, DF | 1 |
| Weber, P | 1 |
| Plaisance, JJ | 1 |
| Mancy, C | 1 |
| Oyofo, BA | 1 |
| Peruski, LF | 1 |
| Ismail, TF | 1 |
| el-Etr, SH | 1 |
| Churilla, AM | 1 |
| Wasfy, MO | 1 |
| Petruccelli, BP | 1 |
| Gabriel, ME | 1 |
| Ozeki, S | 1 |
| Deguchi, T | 1 |
| Yasuda, M | 1 |
| Nakano, M | 1 |
| Kawamura, T | 1 |
| Nishino, Y | 1 |
| Kawada, Y | 1 |
| White, DG | 1 |
| Piddock, LJ | 1 |
| Maurer, JJ | 1 |
| Zhao, S | 1 |
| Ricci, V | 1 |
| Thayer, SG | 1 |
| Orrett, FA | 1 |
| Shurland, SM | 1 |
| Vargas, M | 1 |
| Espasa, M | 1 |
| Pujol, M | 1 |
| Corachán, M | 1 |
| Anta, MTJ | 1 |
| Gascón, J | 1 |
| Barnham, M | 1 |
| Gaya, H | 1 |
| Singh, SN | 1 |
| Singh, S | 1 |
| Singh, KN | 1 |
| Rosen, DI | 1 |
| Marosvári, I | 1 |
| Schmidt, M | 1 |
| Franzblau, AH | 1 |
| Miller, TE | 1 |
| North, D | 1 |
| Burnham, S | 1 |
| Atef, M | 1 |
| Youssef, SA | 1 |
| Amer, AM | 1 |
| el-Banna, HA | 1 |
| Kling, PA | 1 |
| Holmlund, D | 1 |
| Burman, LG | 1 |
| Ishiyama, M | 2 |
| Nakazawa, S | 2 |
| Andreeva, AM | 1 |
| Moroz, AF | 1 |
| Coetzee, M | 1 |
| Leary, PM | 1 |
| Lang, GR | 1 |
| Levin, S | 1 |
| Shaw, EJ | 2 |
| Smith, A | 1 |
| Jackson, H | 1 |
| Economou, G | 1 |
| Ward-McQuaid, N | 1 |
| Nishida, M | 1 |
| Mine, Y | 1 |
| Matsubara, T | 1 |
| Goto, S | 1 |
| Kuwahara, S | 1 |
| Stamey, TA | 2 |
| Loew, H | 2 |
| Ritzerfeld, W | 6 |
| Conte, GF | 1 |
| Pursell, RE | 1 |
| Datta, N | 1 |
| Brumfitt, W | 1 |
| Toivonen, S | 1 |
| Pentikäinen, P | 1 |
| Leirisalo, M | 1 |
| Pyörälä, K | 1 |
| Hoffbrand, BI | 1 |
| Rao, KG | 1 |
| Cederberg, A | 1 |
| Denneberg, T | 1 |
| Ekberg, M | 1 |
| Juhlin, I | 1 |
| Tanaka, T | 1 |
| Kobayashi, A | 1 |
| Ikemura, K | 1 |
| Hashimoto, H | 1 |
| Mitsuhashi, S | 1 |
| Henkel, W | 1 |
| Freiesleben, H | 1 |
| Wöhrmann, W | 1 |
| Commichau, R | 1 |
| Agoston, E | 1 |
| Balogh, E | 1 |
| Simon, L | 1 |
| Farkas, G | 1 |
| Prát, V | 7 |
| Konícková, L | 7 |
| Hatala, M | 3 |
| Urbanová, D | 2 |
| Losse, H | 3 |
| Zapp, E | 1 |
| Broghammer, H | 1 |
| Principi, N | 1 |
| Rosaschino, F | 1 |
| Dall'Acqua, A | 1 |
| Sereni, F | 1 |
| Neogy, KN | 1 |
| De, MS | 1 |
| Chatterjee, ML | 1 |
| Meares, EM | 1 |
| Winningham, DG | 1 |
| Burrous, SE | 1 |
| Cawein, JB | 1 |
| Oshima, Y | 1 |
| Osada, Y | 1 |
| de Andrade, ZM | 1 |
| Zisman, M | 1 |
| de Melo, GO | 1 |
| Loureiro Júnior, L | 1 |
| Anderson, K | 1 |
| English, AR | 1 |
| Lawson, DH | 1 |
| Gleadle, RI | 1 |
| Linton, AL | 1 |
| Ott, JL | 1 |
| Short, LJ | 1 |
| Holmes, DH | 1 |
| Seneca, H | 1 |
| Peer, P | 1 |
| Warren, B | 1 |
| Rudzit, EA | 1 |
| Lisitsa, LI | 1 |
| Kneebone, GM | 1 |
| Gotoh, K | 1 |
| Shinoda, T | 1 |
| Ito, S | 1 |
| Isogai, K | 1 |
| Kimura, T | 1 |
| Ohtani, F | 1 |
| Ishiyama, K | 1 |
| Yamasaki, I | 1 |
| Kato, T | 1 |
| Ogawa, T | 1 |
| Gierup, J | 1 |
| Ljunggren, A | 1 |
| Wójcicki, J | 1 |
3 reviews available for nalidixic acid and E coli Infections
| Article | Year |
|---|---|
Diagnosis and treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Cephalosporins; Chloramphenicol; | 1971 |
Recent changes in bacterial resistance to antibiotics.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Clostridium perfringens; Escherichia coli; Esche | 1974 |
[Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Chronic Disease; Coryneb | 1971 |
7 trials available for nalidixic acid and E coli Infections
| Article | Year |
|---|---|
Pivmecillinam in uncomplicated urinary tract infections in general practice.
Topics: Acute Disease; Amdinocillin Pivoxil; Bacteria; Escherichia coli Infections; Humans; Microbial Sensit | 1981 |
A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
Topics: Adult; Central Nervous System Diseases; Cinoxacin; Clinical Trials as Topic; Escherichia coli Infect | 1981 |
Mictral, a citrated formulation of nalidixic acid in the treatment of acute uncomplicated cystitis. A study in general practice in Scotland and the Irish Republic.
Topics: 4-Quinolones; Acute Disease; Adolescent; Adult; Aged; Anti-Infective Agents; Clinical Trials as Topi | 1981 |
Comparison of cinoxacin and nalidixic acid in patients with cystitis.
Topics: Adult; Aged; Cinoxacin; Cystitis; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Na | 1982 |
Prevention of post-operative infection in appendicectomy by single dose intravenous metronidazole. An open prospective randomised study.
Topics: Adolescent; Adult; Aged; Appendectomy; Appendicitis; Child; Doxycycline; Escherichia coli Infections | 1985 |
Nalidixic acid by intravenous infusion. A report of 50 cases.
Topics: Adolescent; Adult; Aged; Ampicillin; Carbenicillin; Child; Child, Preschool; Clinical Trials as Topi | 1972 |
Comparison of ampicillin and nalidixic acid in the treatment of urinary tract infections caused by E. coli.
Topics: Acute Disease; Adolescent; Adult; Aged; Ampicillin; Chronic Disease; Drug Hypersensitivity; Escheric | 1974 |
132 other studies available for nalidixic acid and E coli Infections
| Article | Year |
|---|---|
Cephalosporin 3'-quinolone esters with a dual mode of action.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciproflox | 1990 |
First report of plasmid-mediated qnrA1 in a ciprofloxacin-resistant Escherichia coli strain in Latin America.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia | 2007 |
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chitosan; Con | 2007 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Esch | 2008 |
High diversity of extended-spectrum beta-lactamases in Escherichia coli isolates from Italian broiler flocks.
Topics: Amplified Fragment Length Polymorphism Analysis; Animals; beta-Lactamases; Cephalosporin Resistance; | 2010 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistan | 2010 |
Molecular characterization and biofilm-formation analysis of Listeria monocytogenes, Salmonella spp., and Escherichia coli isolated from Brazilian swine slaughterhouses.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Biofilms; Brazil; Cefazolin; Chloramphenicol; Doxycycline | 2022 |
Bacterial profile, antimicrobial resistance, and molecular detection of ESBL and quinolone resistance gene of uropathogens causing urinary tract infection in the southeastern part of Bangladesh.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Cefazolin; Drug Resistance | 2023 |
Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; E | 2020 |
The insect antimicrobial peptide cecropin A disrupts uropathogenic Escherichia coli biofilms.
Topics: Animals; Antimicrobial Cationic Peptides; Biofilms; Cell Membrane Permeability; Disease Models, Anim | 2020 |
Wildlife Carnivorous Mammals As a Specific Mirror of Environmental Contamination with Multidrug-Resistant
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Chloramphenicol; Drug Resis | 2020 |
Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Caenorhabditis el | 2021 |
Phenotypic and Genotypic Characterization of Clinical Enterotoxigenic Escherichia coli Isolates from Shenzhen, China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cep | 2017 |
Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multipl | 2018 |
An empirical comparison of isolate-based and sample-based definitions of antimicrobial resistance and their effect on estimates of prevalence.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Esc | 2018 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistan | 2018 |
Prevalence and characterization of Escherichia coli isolated from the Upper Oconee Watershed in Northeast Georgia.
Topics: Ampicillin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Enteropathogenic Escherichi | 2018 |
Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dipeptides; Drug Resistance, Multiple, Bac | 2014 |
Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
Topics: Acute Disease; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Catchment Area, Heal | 2014 |
Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Catchment Area, Health; Cohort St | 2014 |
High levels of multiresistance in quinolone resistant urinary tract isolates of Escherichia coli from Norway; a non clonal phenomen?
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escher | 2014 |
[Role of double strand DNA break repair for quinolone sensitivity in Escherichia coli: therapeutic implications].
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Breaks, Double-Stranded; DNA Helicases | 2015 |
Environmental phosphate differentially affects virulence phenotypes of uropathogenic Escherichia coli isolates causative of prostatitis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cellulose; Ciprofloxacin; Escheric | 2015 |
Antimicrobial resistance of Escherichia coli isolated in newly-hatched chickens and effect of amoxicillin treatment during their growth.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Infective Agents; Chickens; Drug Resistance, Multiple, | 2016 |
Prevalence, antimicrobial resistance and multiple-locus variable-number tandem-repeat analysis profiles of diarrheagenic Escherichia coli isolated from different retail foods.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cattle; Cephalothin; Enteropathogenic Escherichia coli; | 2017 |
Impact of persistent bovine viral diarrhea viral infection on the duration and level of shedding of Escherichia coli O157 in calves.
Topics: Animals; Animals, Newborn; Bovine Virus Diarrhea-Mucosal Disease; Cattle; Cattle Diseases; Colony Co | 2008 |
Distribution and possible transmission of ampicillin- and nalidixic acid-resistant Escherichia coli within the broiler industry.
Topics: Ampicillin; Ampicillin Resistance; Amplified Fragment Length Polymorphism Analysis; Animals; Anti-Ba | 2010 |
Comparison of the effects of different nutrient media on production of heat-stable enterotoxin-b by Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Culture Media; Drug Resistance, Bacterial; Enterot | 2010 |
Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Denmark; DNA Topoisomerases; Drug Resistance, Bacterial; Elect | 2011 |
Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA, Bacterial; Drug Re | 2011 |
[Prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr among ESBL producing enterobacteria isolates from Chilean hospitals].
Topics: Acetylation; Anti-Bacterial Agents; Bacterial Proteins; Chile; Ciprofloxacin; Cross Infection; Drug | 2012 |
An attenuated mutant of avian pathogenic Escherichia coli serovar O78: a possible live vaccine strain for prevention of avian colibacillosis.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Antigens, Bacterial; Chick Embryo; Chic | 2012 |
Extraintestinal pathogenic Escherichia coli in poultry meat products on the Finnish retail market.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Chickens; Ciprofloxacin; Colony Count, Microbial; D | 2012 |
Prevalence of plasmid-mediated quinolone resistance determinants among Escherichia coli isolated from food animals in Korea.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Ciprofloxacin; Cluster Analysis; DNA Gyrase | 2012 |
Are quinolone-resistant uropathogenic Escherichia coli less virulent?
Topics: Anti-Infective Agents; Bacterial Toxins; Ciprofloxacin; Cystitis; Cytotoxins; Drug Resistance, Micro | 2002 |
Variation in the persistence of Escherichia coli O157:H7 in experimentally inoculated 6-week-old conventional lambs.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Infective Agents; Bacterial Adhesion; Cecum; C | 2002 |
An outbreak of heat-stable enterotoxin-producing Escherichia coli O25:HNM resistant to nalidixic acid caused by ingestion of contaminated box-lunch in September-October 2002 in Hyogo and Shiga Prefectures.
Topics: Adult; Aged; Anti-Infective Agents; Bacterial Toxins; Disease Outbreaks; Drug Resistance, Bacterial; | 2002 |
Isolation and molecular characterization of nalidixic acid-resistant extraintestinal pathogenic Escherichia coli from retail chicken products.
Topics: Animals; Anti-Infective Agents; Chickens; Cluster Analysis; Drug Resistance, Bacterial; Escherichia | 2003 |
A clinical trial of the treatment of gram-negative urinary infections with nalidixic acid.
Topics: Anti-Infective Agents; Escherichia coli Infections; Nalidixic Acid; Naphthyridines; Proteus Infectio | 1963 |
A clinical trial of nalidixic acid (Negram, WIN. 18,320) in thirty-three patients with urinary infections treated in general practice.
Topics: Anti-Infective Agents; Escherichia coli Infections; General Practice; Nalidixic Acid; Naphthyridines | 1963 |
NALIDIXIC ACID IN INFECTIONS OF URINARY TRACT. LABORATORY AND CLINICAL INVESTIGATIONS.
Topics: Anti-Bacterial Agents; Drug Resistance; Drug Resistance, Microbial; Enterococcus faecalis; Escherich | 1963 |
NALIDIXIC ACID IN URINARY INFECTIONS.
Topics: Animals; Dogs; Drug Resistance; Drug Resistance, Microbial; Escherichia coli Infections; Haplorhini; | 1963 |
USE OF NALIDIXIC ACID IN THE TREATMENT OF URINARY TRACT INFECTIONS.
Topics: Drug Resistance; Drug Resistance, Microbial; Enterobacter; Escherichia coli Infections; Nalidixic Ac | 1964 |
[NALIDIXIC ACID: A NEW ANTIBACTERIAL AGENT].
Topics: Anti-Bacterial Agents; Escherichia coli Infections; Klebsiella; Nalidixic Acid; Naphthyridines; Pseu | 1964 |
[TREATMENT OF URINARY TRACT INFECTIONS WITH NALIDIXIC ACID (WINTOMILON)].
Topics: Blood; Cystitis; Drug Therapy; Escherichia coli Infections; Klebsiella; Nalidixic Acid; Naphthyridin | 1964 |
CXCVII. NALIDIXIC ACID.
Topics: Anti-Infective Agents; Enterobacter aerogenes; Enterobacteriaceae; Escherichia coli Infections; Nali | 1964 |
THERAPEUTIC PROBLEMS IN URINARY INFECTIONS.
Topics: Chloramphenicol; Enterobacter aerogenes; Escherichia coli Infections; Humans; Hydrocortisone; Imidaz | 1964 |
A CLINICAL TRIAL OF NALIDIXIC ACID: A NEW ANTIBACTERIAL SUBSTANCE.
Topics: Alcaligenes; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance; Drug Resistance, Microbi | 1964 |
TREATMENT OF URINARY TRACT INFECTION WITH NALIDIXIC ACID.
Topics: Adolescent; Biomedical Research; Child; Escherichia coli Infections; Geriatrics; Nalidixic Acid; Nap | 1964 |
CLINICAL EVALUATION OF NEGGRAM, A NEW ANTIMICROBIAL AGENT: PRELIMINARY REPORT.
Topics: Anti-Infective Agents; Biomedical Research; Cystitis; Drug Resistance; Drug Resistance, Microbial; E | 1964 |
STUDY OF NALIDIXIC ACID.
Topics: Anti-Infective Agents; Biomedical Research; Drug Therapy; Enterobacter aerogenes; Escherichia coli I | 1965 |
CHILD CARE IN GENERAL PRACTICE. URINARY INFECTION.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Child; Child Care; Diagnosis; Drug Therapy; Enterobact | 1965 |
TREATMENT OF PYELONEPHRITIS: BACTERIAL, DRUG AND HOST FACTORS IN SUCCESS OR FAILURE AMONG 252 PATIENTS.
Topics: Anti-Bacterial Agents; Chloramphenicol; Colistin; Drug Resistance; Drug Resistance, Microbial; Drug | 1965 |
A CLINICAL TRIAL OF NALIDIXIC ACID (NEGRAM) IN URINARY INFECTIONS.
Topics: Adolescent; Anti-Infective Agents; Biomedical Research; Child; Drug Therapy; Escherichia coli Infect | 1965 |
TISSUE CONCENTRATION OF NALIDIXIC ACID IN CHRONIC PYELONEPHRITIS.
Topics: Anti-Infective Agents; Drug Therapy; Escherichia coli Infections; Nalidixic Acid; Naphthyridines; Pr | 1965 |
Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; | 2003 |
Quinolone resistance among Escherichia coli strains from community-acquired urinary tract infections in Greece.
Topics: Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; DNA Gyrase; DNA Topoisomerase I | 2004 |
[E. coli: resistance to quinolones and beta-lactams of clinical strains isolated in the Franche-Comté region of France].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ceftazidime; | 2004 |
Acquisition and epidemiology of antibiotic-resistant Escherichia coli in a cohort of newborn calves.
Topics: Ampicillin; Ampicillin Resistance; Animals; Animals, Newborn; Anti-Bacterial Agents; Anti-Infective | 2004 |
Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe.
Topics: Anti-Infective Agents; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Escherichia | 2005 |
[Activity of nalidixic acid and fluoroquinolones on Escherichia coli strains isolated from non-complicated urinary infections (reseau TSN - France, 1999 - 2001)].
Topics: Adolescent; Adult; Anti-Infective Agents; Drug Resistance, Microbial; Escherichia coli; Escherichia | 2004 |
Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.
Topics: Anti-Infective Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Es | 2005 |
Drug-resistant Escherichia coli, Rural Idaho.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Cephalosporins; Child; Child, Preschool; Dr | 2005 |
Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.
Topics: Anti-Bacterial Agents; DNA Gyrase; DNA Topoisomerase IV; Electrophoresis, Gel, Pulsed-Field; Escheri | 2006 |
Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates.
Topics: Ampicillin; Anti-Infective Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli In | 2006 |
In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Topoisomerases; Drug Resistance; Escherichia coli; Esch | 2006 |
Evaluation of a survey approach to estimating the prevalence of cattle carrying antimicrobial-resistant Escherichia coli.
Topics: Ampicillin; Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Drug Resistance, Bacterial; Esc | 2008 |
Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.
Topics: Anti-Bacterial Agents; Chloramphenicol Resistance; Escherichia coli; Escherichia coli Infections; Ge | 2007 |
Optimization of the use of ciprofloxacin.
Topics: Anti-Infective Agents; Cell Division; Ciprofloxacin; Colony-Forming Units Assay; Dose-Response Relat | 2009 |
Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Denmark; Drug Resistance, Bacteri | 2008 |
Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Escherichia coli Infections; Klebsiella Infect | 1983 |
Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
Topics: Anti-Infective Agents, Urinary; Drug Resistance, Microbial; Escherichia coli Infections; Humans; In | 1984 |
Effect of a three-day course of nalidixic acid in the frequency-dysuria syndrome with significant bacteriuria in women.
Topics: Adolescent; Adult; Aged; Bacteriuria; Drug Resistance, Microbial; Escherichia coli; Escherichia coli | 1983 |
[Detection of Escherichia coli K99+ in the feces of cows and their calves].
Topics: Animals; Animals, Newborn; Cattle; Cattle Diseases; Diarrhea; Disease Outbreaks; Drug Resistance, Mi | 1983 |
Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
Topics: Animals; Anti-Infective Agents; Diffusion; Endocarditis, Bacterial; Escherichia coli Infections; Fur | 1984 |
[Cinobar, a new antimicrobial agent for the treatment of urinary infections].
Topics: Adult; Cinoxacin; Escherichia coli Infections; Female; Humans; Male; Nalidixic Acid; Pyridazines; Ra | 1980 |
[Therapy of noncomplicated urinary tract infections in women].
Topics: Ampicillin; Escherichia coli Infections; Female; Humans; Nalidixic Acid; Nitrofurantoin; Pipemidic A | 1981 |
Lack of increase in resistance to quinolones in general practice isolates of Escherichia coli.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Clavulanic Acids; | 1994 |
Enteropathogens associated with diarrhea among military personnel during Operation Bright Star 96, in Alexandria, Egypt.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Antigens, Bacterial; Bacterial Proteins; Blas | 1997 |
Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Asparagine; Ciprofloxacin; DNA Gyrase; DNA Topoisomerases, Type II; DNA, Bact | 1997 |
Characterization of fluoroquinolone resistance among veterinary isolates of avian Escherichia coli.
Topics: Animals; Anti-Infective Agents; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, | 2000 |
Prevalence of resistance to antimicrobials of Escherichia coli isolates from clinical sources at a private hospital in Trinidad.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Cephal | 2001 |
Susceptibility patterns of enteroaggregative Escherichia coli associated with traveller's diarrhoea: emergence of quinolone resistance.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Diarrhea; DNA Gyrase; DNA Topoisomerase IV; Drug Resis | 2001 |
In vitro susceptibility of urinary isolates of Escherichia coli to cinoxacin.
Topics: Cinoxacin; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nalid | 1979 |
Nalidixic acid against urinary tract pathogens.
Topics: Escherichia coli Infections; Female; Humans; Male; Nalidixic Acid; Urinary Tract Infections | 1979 |
Five-day course of antibacterials for uncomplicated urinary infections.
Topics: Adult; Anti-Bacterial Agents; Bacteriuria; Carbenicillin; Cephalexin; Child; Drug Administration Sch | 1976 |
[Oxolinic acid therapy of urinary tract infections in infancy].
Topics: Anti-Infective Agents, Urinary; Child, Preschool; Drug Resistance, Microbial; Escherichia coli Infec | 1976 |
Regional differences in patterns of urinary tract infections.
Topics: Canada; Citrobacter; Colistin; Drug Evaluation, Preclinical; Epidemiologic Methods; Escherichia coli | 1975 |
Acquiescent renal infection.
Topics: Animals; Escherichia coli Infections; Female; Gentamicins; Immunity; Kidney; Kidney Concentrating Ab | 1975 |
Influence of E. coli infection on the disposition kinetic of nalidixic acid in broiler chickens.
Topics: Administration, Oral; Animals; Chickens; Escherichia coli Infections; Female; Injections, Intramuscu | 1992 |
[Microbiological studies on the combination effect of rifampicin and nalidixic acid (author's transl)].
Topics: Animals; DNA, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacter; Escherichia coli; | 1974 |
[Development of resistance to nalidixic acid in experiments in vitro and cross resistance with other preparation in pathogenic and nonpathogenic strains of E. coli].
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cephaloridine; Child; Chloramphenicol; Chlortetracycline; | 1968 |
Gentamicin in Esch. coli gastroenteritis.
Topics: Ampicillin; Chloramphenicol; Colistin; Entamoeba histolytica; Escherichia coli; Escherichia coli Inf | 1971 |
Recurrent urinary infections in a girl.
Topics: Child, Preschool; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Hydroneph | 1972 |
Bicyclomycin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Blood Proteins; Bridged-Ring Compounds; Drug Resistance, M | 1972 |
The role of introital enterobacteria in recurrent urinary infections.
Topics: Adult; Bacteriological Techniques; Escherichia coli; Escherichia coli Infections; Female; Humans; Ma | 1972 |
Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Escherichia coli Infections; Nalidixic Acid; | 1973 |
[Therapy of infectious gastroenteritis in infants. Comparative study of a new drug].
Topics: Drug Combinations; Escherichia coli Infections; Gastroenteritis; Humans; Infant; Kaolin; Nalidixic A | 1973 |
R factors in Enterobacteriaceae causing urinary-tract infection in general practice in 1962-63 and 1968-69.
Topics: Ampicillin; Chloramphenicol; Escherichia coli; Escherichia coli Infections; Family Practice; Humans; | 1973 |
Letter: Interaction of nalidixic acid and warfarin.
Topics: Drug Interactions; Drug Synergism; Escherichia coli Infections; Female; Humans; Middle Aged; Nalidix | 1974 |
Pseudotumor cerebri associated with nalidixic acid.
Topics: Child; Escherichia coli Infections; Female; Humans; Nalidixic Acid; Papilledema; Pseudotumor Cerebri | 1974 |
Nalidixic acid in urinary tract infections with particular reference to the emergence of resistance.
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteriological Techniques; Bacteriuria; Chronic Disease; Cu | 1974 |
Drug resistance and distribution of R factors among Escherichia coli strains.
Topics: Ampicillin; Cephaloridine; Chloramphenicol; Colistin; Conjugation, Genetic; Escherichia coli; Escher | 1974 |
[Serum resistance and "nephropathogenicity" of E. coli. IV. Changes of virulence in vitro and in vivo].
Topics: Ampicillin; Animals; Blood Bactericidal Activity; Chloramphenicol; Chronic Disease; Disease Models, | 1974 |
Changes in resistance of the bacterial flora among patients seen at the Ist department of surgery of the Szeged University during the past 5 years.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteriuria; Chloramphenicol; Col | 1974 |
Evaluation of the antibacterial effect of nalidixic acid in two experimental models of Escherichia coli pyelonephritis.
Topics: Animals; Bacteriological Techniques; Escherichia coli Infections; Injections, Intravenous; Kidney; K | 1968 |
Urinary antiseptics.
Topics: Anti-Infective Agents, Urinary; Escherichia coli Infections; Humans; Hydrogen-Ion Concentration; Man | 1968 |
[Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
Topics: Animals; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Mice; Nalidixic | 1968 |
[Experience with nalidixic acid in pyelonephritis in children].
Topics: Child; Child, Preschool; Escherichia coli Infections; Humans; Infant; Kidney; Kidney Calculi; Nalidi | 1968 |
[Therapy of experimental ascending E. coli pyelonephritis with anlidixic acid].
Topics: Animals; Escherichia coli Infections; Male; Nalidixic Acid; Pyelonephritis; Rabbits | 1968 |
[Therapy results with nalidixic acid in chronic urinary tract infection].
Topics: Aged; Anti-Bacterial Agents; Bacteria; Chronic Disease; Drug Resistance, Microbial; Escherichia coli | 1968 |
[Etiological, diagnostic and therapeutic considerations on infections of the infantile urinary tract].
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Microbial; Escherichia coli Infecti | 1967 |
Nalidixic acid in urinary infection.
Topics: Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli Infections; Female; Humans; Klebsie | 1968 |
[Prophylaxis of urinary tract infections in rats by long-term chemotherapy].
Topics: Animals; Escherichia coli Infections; Female; Nalidixic Acid; Nitrofurantoin; Proteus Infections; Ra | 1969 |
[Nalidixic acid level during experimental acute pyelonephritis].
Topics: Animals; Escherichia coli Infections; Female; Nalidixic Acid; Pyelonephritis; Rats | 1969 |
Chronic bacterial prostatitis and the diffusion of drugs into prostatic fluid.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Chronic Disease; Diffusion; Dogs; Erythromycin; Escheric | 1969 |
Rat pyelonephritis model suitable for primary or secondary screening.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Escherich | 1969 |
[Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
Topics: Animals; Disease Models, Animal; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infe | 1969 |
[Experimental cystitis in rats and its chemotherapy].
Topics: Animals; Bacteriuria; Cystitis; Disease Models, Animal; Escherichia coli; Escherichia coli Infection | 1970 |
[Bacteriological studies on rifampicin, a new antibiotic. 2. Antimicrobial activity of desacetyl-rifampicin].
Topics: Animals; Bacteria; Drug Resistance, Microbial; Escherichia coli Infections; Mice; Microbial Sensitiv | 1970 |
[Use of nalidixic acid in infectious diseases of full-term and premature newborn infants].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Escherichia coli; Escherichia coli Infections; Fe | 1970 |
The antibiotic sensitivity of 100 isolates of Escherichia coli, with special reference to the domiciliary treatment of urinary tract infections.
Topics: Ampicillin; Anti-Infective Agents, Urinary; Australia; Escherichia coli; Escherichia coli Infections | 1970 |
Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats.
Topics: Animals; Cell Count; Disease Models, Animal; Escherichia coli Infections; Female; Kidney; Nalidixic | 1971 |
Extended therapy in patients with established urinary tract infection.
Topics: Adolescent; Adult; Aged; Ampicillin; Anti-Infective Agents, Urinary; Chronic Disease; Escherichia co | 1971 |
The problems of drug-resistant pathogenic bacteria. In vitro and in vivo methodology for detecting and evaluating inhibitors of transfer of resistance factors.
Topics: Animals; Anti-Bacterial Agents; Conjugation, Genetic; Drug Resistance, Microbial; Escherichia coli; | 1971 |
The treatment of phosphatic encrusted cystitis (alkaline cystitis) with nalidixic acid.
Topics: Cystitis; Escherichia coli Infections; Humans; Nalidixic Acid; Phosphates; Proteus Infections | 1966 |
Efficacy of drugs in gram negative urinary pathogens.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Enterobacter; Escherichia; Escher | 1968 |
A clinical appraisal of nalidixic acid in urinary tract infection in childhood.
Topics: Adolescent; Child; Escherichia coli Infections; Female; Humans; Male; Nalidixic Acid; Proteus Infect | 1965 |
[Clinical use of Wintomylon (nalidixic acid) in the field of urology].
Topics: Adolescent; Adult; Aged; Child; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Nali | 1965 |
[Clinical evaluation of Wintomylon (nalidixic acid) in the urinary tract infections].
Topics: Adult; Aged; Child, Preschool; Escherichia coli Infections; Humans; Middle Aged; Nalidixic Acid; Uri | 1965 |
[Nalidixic acid in the treatment of complicated urinary tract infections in children].
Topics: Child; Child, Preschool; Escherichia coli Infections; Humans; Nalidixic Acid; Proteus Infections; Ps | 1966 |
[Nalidixic acid].
Topics: Escherichia coli Infections; Humans; Nalidixic Acid; Proteus Infections; Urinary Tract Infections | 1967 |